ImpediMed Limited IPDQF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.41% | 20.74% | 20.60% | 20.21% | 21.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.41% | 20.74% | 20.60% | 20.21% | 21.55% |
| Cost of Revenue | 10.81% | 23.25% | 37.65% | 33.54% | 30.89% |
| Gross Profit | 21.94% | 20.37% | 18.26% | 18.33% | 20.19% |
| SG&A Expenses | 4.03% | 7.10% | 9.93% | 3.97% | -0.18% |
| Depreciation & Amortization | -3.03% | 12.23% | 32.21% | 58.16% | 99.87% |
| Other Operating Expenses | 23.26% | -17.53% | -40.88% | -32.42% | -19.20% |
| Total Operating Expenses | 5.13% | 5.57% | 5.59% | 4.87% | 5.62% |
| Operating Income | 3.31% | 2.55% | 2.20% | 2.53% | 1.51% |
| Income Before Tax | -12.52% | -12.61% | -12.26% | -13.20% | -15.87% |
| Income Tax Expenses | 5.36% | 11.66% | 17.61% | -5.85% | -22.22% |
| Earnings from Continuing Operations | -12.51% | -12.61% | -12.27% | -13.18% | -15.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.51% | -12.61% | -12.27% | -13.18% | -15.81% |
| EBIT | 3.31% | 2.55% | 2.20% | 2.53% | 1.51% |
| EBITDA | 3.03% | 2.27% | 2.59% | 5.57% | 7.18% |
| EPS Basic | -8.11% | -11.27% | -14.71% | -15.15% | -15.63% |
| Normalized Basic EPS | -4.26% | -6.67% | -11.63% | -6.82% | -6.82% |
| EPS Diluted | -8.11% | -11.27% | -14.71% | -15.15% | -15.63% |
| Normalized Diluted EPS | -4.26% | -6.67% | -11.63% | -6.82% | -6.82% |
| Average Basic Shares Outstanding | 5.70% | 2.88% | 0.07% | -0.03% | -0.13% |
| Average Diluted Shares Outstanding | 5.70% | 2.88% | 0.07% | -0.03% | -0.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |